Left Ventricular Hypertrophy in Nondiabetics Patients with Predialysis Chronic Renal Disease in the Hospital Center Elbasan
Abstract
Background: Cardiovascular disease (CVD) is still the major cause of death in patients with end stage chronic kidney disease (ES-CKD), with a mortality rate approximately 10 to 30 times greater than that of the general population. Multiple factors are involved in the development of CVD in CKD. Although left ventricular hypertrophy (LVH) is strong predictor of mortality in patients with end-stage renal disease, few studies are available before the start of dialysis treatment in our country. The purpose of this study is to evaluate the prevalence and clinical correlates of LVH in nondiabetic patients with chronic kidney disease (CKD) not yet undergoing renal replacement therapy and to examine the relations between anemia, pulse pressure (PP), hypertension (HTA) with left ventricular hypertrophy (LVH). Materials and methods: We investigated 111 nondiabetic patients with CKD, presented in ambulatory service. Patients excluded from the study were of ischemic heart and valvular heart disease. 26 patients presented the second stage of CKD (GFR 60-89,9ml/min). 30 patients presented third stage of CKD (GFR 30–59,9ml/min). 32 patients was at the 4th stage of CDK (GFR 15-29,9 ml /min) and 23 patients presented 5 the stage of CKD (GFR <15ml/min). Each patient had blood pressure (BP) measured by means of 24-hour ambulatory BP monitoring and left ventricular mass index (LVMi) assessed by means of M-mode echocardiography. Creatinine clearance was estimated by means of the Cockcroft-Gault formula, and hemoglobin was assessed by using routine methods. Results: The prevalence of LVH in nondiabetic predialysis patients with CKD was 81.9%; 22% of whom were women. The prevalence of hypertension was 72,6%. Anemia was present in all patients. In the overall group, prevalences of arterial hypertension, anemia and LVH were high. HTA is associated with LVH in patients with CKD, and the strong relationship between elevated pulse pressure and LVH in those with more advanced CKD suggests that increased arterial stiffness might have a role for LVH well before the start of dialysis therapy. Conclusions: In conclusion, the incidence of LVH was high even among nondiabetics patients under conservative treatment, and, except for age, LVH correlated with reversible factors. The need for strictly diagnosing CKD and preventing LVH in the predialysis phase is emphasized to decrease mortality due to CVD in that population.
Keywords: Chronic Kidney Disease, Left ventricular hypertrophy; pulse pressure, hypertension, anemia.
Downloads
Published
How to Cite
Issue
Section
License
Declaration/Copyright transfer:
1. In consideration of the undertaking set out in paragraph 2, and upon acceptance by ANGLISTICUM for publication of the manuscript in the Journal, I/We hereby assign and transfer publication rights to ANGLISTICUM, whereas I/We retain the copyright for the manuscript. This assignment provides ANGLISTICUM the sole right and responsibility to publish the manuscript in its printed and online version, and/or in other media formats.
2. In consideration of this assignment, ANGLISTICUM hereby undertakes to prepare and publish the manuscript in the Journal, subject only to its right to refuse publication if there is a breach of the Author’s warranty in paragraph 4 or if there are other reasonable grounds.
3. Editors and the editorial board of ANGLISTICUM are empowered to make such editorial changes as may be necessary to make the Manuscript suitable for publication.
4. I/We hereby acknowledge that: (a) The manuscript submitted is an original work and that I/We participated in the work substantively and thus I/We hereby are prepared to take public responsibility for the work; (b) I/We hereby have seen and approved the manuscript as submitted and that the manuscript has not either been published, submitted or considered for publication elsewhere; (c) The text, illustration, and any other materials included in the manuscript do not infringe upon any existing copyright or other rights of anyone.
5. I/We hereby indemnify ANGLISTICUM and the respective Editors of the Journal as mentioned in paragraph 3, and hold them harmless from any loss, expense or damage occasioned by a claim or suit by a third party for copyright infringement, or any suit arising out of any breach of the foregoing warranties as a result of publication of the manuscript.